Search results
Results From The WOW.Com Content Network
Radionuclide angiography is an area of nuclear medicine which specialises in imaging to show the functionality of the right and left ventricles of the heart, thus allowing informed diagnostic intervention in heart failure. It involves use of a radiopharmaceutical, injected into a patient, and a gamma camera for acquisition.
Technetium (99m Tc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. [1] It is a renal imaging agent that is given by intravenous injection. [1] It was approved for medical use in the United States in June 1990. [2]
Common side effects of ioflupane (123 I) are headache, vertigo, increased appetite and formication. Less than 1% of patients experience pain at the injection site. [7] The radiation risks are reported as low. The committed effective dose for a single investigation on a 70 kg individual is 4.6 mSv. [11] Pregnant patients should not undergo the test.
Technetium (99m Tc) tetrofosmin is a drug used in nuclear medicine cardiac imaging.It is sold under the brand name Myoview (GE Healthcare).The radioisotope, technetium-99m, is chelated by two 1,2-bis[di-(2-ethoxyethyl)phosphino]ethane ligands which belong to the group of diphosphines and which are referred to as tetrofosmin.
Nuclear medicine tests differ from most other imaging modalities in that nuclear medicine scans primarily show the physiological function of the system being investigated as opposed to traditional anatomical imaging such as CT or MRI. Nuclear medicine imaging studies are generally more organ-, tissue- or disease-specific (e.g.: lungs scan ...
Technetium 99m Tc albumin aggregated (99m Tc-MAA) is an injectable radiopharmaceutical used in nuclear medicine. It consists of a sterile aqueous suspension of Technetium-99m (99m Tc) labeled to human albumin aggregate particles. It is commonly used for lung perfusion scanning.
Technetium (99m Tc) sestamibi (commonly sestamibi; USP: technetium Tc 99m sestamibi; trade name Cardiolite) is a pharmaceutical agent used in nuclear medicine imaging. The drug is a coordination complex consisting of the radioisotope technetium-99m bound to six (sesta=6) methoxyisobutylisonitrile (MIBI) ligands. The anion is not defined.
Various approaches to approve effectiveness and limit side effects are being investigated, including radiosensitising drugs, fractionation regimes and new radionuclides. [16] Alpha emitters, which have much shorter ranges in tissue (limiting the effect on nearby healthy tissue), such as bismuth-213 or actinium-225 labelled DOTATOC are of ...